Modern Therapeutic Approach towards Schizophrenia: A Comprehensive Review of Contemporary Treatment Strategies and Emerging Innovations

Schizophrenia represents one of the most challenging psychiatric disorders, which affects about 1% of the global population and ranks between the main causes of disability worldwide. This extensive review examines the modern therapeutic landscape of schizophrenia, including recent advances from 2020 to 2025. The article synthesizes the current evidence on medicinal intervention, psychological treatment and emerging medical form. In particular, the recent FDA approval of the KarXT (Cobenfy) in September 2024 marks the first novel mechanism of action in schizophrenia treatment in more than 70 years, which represents a paradigm change from traditional dopamine-targeted remedies. This review analyses the efficacy, safety profile and clinical implications of current treatments, discovering future instructions in accurate medical, digital medical and circuit-based interventions. Integration of individual treatment approaches, enhanced psychosocial intervention, and novels provide unprecedented opportunities to improve results in individuals with medicinal target schizophrenia.